New Key Statistics Module, Z-Score and F-Score
NYSE:TEVA Key Ratios
Market Cap $ M | 15,678.18 |
Enterprise Value $ M | 32,960.75 |
P/E(ttm) | -- |
PE Ratio without NRI | 5.51 |
Forward PE Ratio | 5.79 |
Price/Book | 2.08 |
Price/Sales | 1.01 |
Price/Free Cash Flow | 18.54 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 15,846.00 |
EPS (TTM) $ | -0.47 |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 81.38 |
EV-to-EBITDA | 21.16 |
PEG | -- |
Shares Outstanding M | 1,120.99 |
Net Margin (%) | -3.53 |
Operating Margin % | 20.14 |
Pre-tax Margin (%) | -3.94 |
Quick Ratio | 0.69 |
Current Ratio | 1.02 |
ROA % (ttm) | -1.29 |
ROE % (ttm) | -7.52 |
ROIC % (ttm) | 8.33 |
Dividend Yield % | -- |
Altman Z-Score | 0.24 |
Piotroski F-Score | 5.00 |
Positive ROA | N |
Positive CFROA | Y |
Higher ROA y-y | Y |
Cash flow > Earnings | Y |
Lower Leverage y-y | N |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
TEVA Number of Guru Trades
TEVA Volume of Guru Trades
Gurus Latest Trades with NYSE:TEVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TEVA is held by these investors
Total 2
Teva Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about NYSE:TEVA
Total 0- 1